Literature DB >> 18370102

Quantitative expression profiling of RNA from formalin-fixed, paraffin-embedded tissues using randomly assembled bead arrays.

Marina Bibikova1, Joanne M Yeakley, Jessica Wang-Rodriguez, Jian-Bing Fan.   

Abstract

Formalin-fixed, paraffin-embedded (FFPE) tissues represent an invaluable resource for gene expression analysis, as they are the most widely available materials for studies of human disease. However, degradation of RNA during tissue fixation and storage makes FFPE-derived RNAs hard to work with using conventional microarray technology. Most gene expression studies done using FFPE tissues rely on quantitative RT-PCR (qPCR), but this approach has had limited success because of the short cDNA templates available in these samples. In this chapter, we describe the DASL (cDNA-mediated annealing, selection, extension, and ligation) Assay, a flexible, sensitive, and reproducible gene expression profiling system for parallel analysis of several hundred mRNA transcripts on the BeadArray platform. This technology is especially useful for determining cancer prognosis or therapy response, because it allows not only prospective studies but also retrospective analyses. Using the DASL Assay, gene expression analyses can be performed on routinely stored tumor specimens from patients with known outcomes.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18370102     DOI: 10.1007/978-1-59745-188-8_11

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  13 in total

1.  Quantitative expression profiling in formalin-fixed paraffin-embedded samples by affymetrix microarrays.

Authors:  Diana Abdueva; Michele Wing; Betty Schaub; Timothy Triche; Elai Davicioni
Journal:  J Mol Diagn       Date:  2010-06-03       Impact factor: 5.568

2.  Gene expression profiling of paraffin-embedded primary melanoma using the DASL assay identifies increased osteopontin expression as predictive of reduced relapse-free survival.

Authors:  Caroline Conway; Angana Mitra; Rosalyn Jewell; Juliette Randerson-Moor; Samira Lobo; Jérémie Nsengimana; Sara Edward; D Scott Sanders; Martin Cook; Barry Powell; Andy Boon; Faye Elliott; Floor de Kort; Margaret A Knowles; D Timothy Bishop; Julia Newton-Bishop
Journal:  Clin Cancer Res       Date:  2009-11-03       Impact factor: 12.531

3.  Identification and validation of gene expression models that predict clinical outcome in patients with early-stage laryngeal cancer.

Authors:  E Fountzilas; K Markou; K Vlachtsis; A Nikolaou; P Arapantoni-Dadioti; E Ntoula; G Tassopoulos; M Bobos; P Konstantinopoulos; G Fountzilas; D Spentzos
Journal:  Ann Oncol       Date:  2012-01-04       Impact factor: 32.976

4.  Analysis of multiple sarcoma expression datasets: implications for classification, oncogenic pathway activation and chemotherapy resistance.

Authors:  Panagiotis A Konstantinopoulos; Elena Fountzilas; Jeffrey D Goldsmith; Manoj Bhasin; Kamana Pillay; Nancy Francoeur; Towia A Libermann; Mark C Gebhardt; Dimitrios Spentzos
Journal:  PLoS One       Date:  2010-04-01       Impact factor: 3.240

5.  A novel approach for reliable microarray analysis of microdissected tumor cells from formalin-fixed and paraffin-embedded colorectal cancer resection specimens.

Authors:  Silke Lassmann; Clemens Kreutz; Anja Schoepflin; Ulrich Hopt; Jens Timmer; Martin Werner
Journal:  J Mol Med (Berl)       Date:  2008-12-06       Impact factor: 4.599

6.  A microRNA activity map of human mesenchymal tumors: connections to oncogenic pathways; an integrative transcriptomic study.

Authors:  Elena Fountzilas; Andrew D Kelly; Antonio R Perez-Atayde; Jeffrey Goldsmith; Panagiotis A Konstantinopoulos; Nancy Francoeur; Mick Correll; Renee Rubio; Lan Hu; Mark C Gebhardt; John Quackenbush; Dimitrios Spentzos
Journal:  BMC Genomics       Date:  2012-07-23       Impact factor: 3.969

7.  Expression profiling of formalin-fixed paraffin-embedded primary breast tumors using cancer-specific and whole genome gene panels on the DASL® platform.

Authors:  Monica M Reinholz; Jeanette E Eckel-Passow; S Keith Anderson; Yan W Asmann; Michael A Zschunke; Ann L Oberg; Ann E McCullough; Amylou C Dueck; Beiyun Chen; Craig S April; Eliza Wickham-Garcia; Robert B Jenkins; Julie M Cunningham; Jin Jen; Edith A Perez; Jian-Bing Fan; Wilma L Lingle
Journal:  BMC Med Genomics       Date:  2010-12-20       Impact factor: 3.063

8.  Gene expression profiles from formalin fixed paraffin embedded breast cancer tissue are largely comparable to fresh frozen matched tissue.

Authors:  Lorenza Mittempergher; Jorma J de Ronde; Marja Nieuwland; Ron M Kerkhoven; Iris Simon; Emiel J Th Rutgers; Lodewyk F A Wessels; Laura J Van't Veer
Journal:  PLoS One       Date:  2011-02-11       Impact factor: 3.240

9.  3'-end sequencing for expression quantification (3SEQ) from archival tumor samples.

Authors:  Andrew H Beck; Ziming Weng; Daniela M Witten; Shirley Zhu; Joseph W Foley; Phil Lacroute; Cheryl L Smith; Robert Tibshirani; Matt van de Rijn; Arend Sidow; Robert B West
Journal:  PLoS One       Date:  2010-01-19       Impact factor: 3.240

10.  MicroRNA paraffin-based studies in osteosarcoma reveal reproducible independent prognostic profiles at 14q32.

Authors:  Andrew D Kelly; Benjamin Haibe-Kains; Katherine A Janeway; Katherine E Hill; Eleanor Howe; Jeffrey Goldsmith; Kyle Kurek; Antonio R Perez-Atayde; Nancy Francoeur; Jian-Bing Fan; Craig April; Hal Schneider; Mark C Gebhardt; Aedin Culhane; John Quackenbush; Dimitrios Spentzos
Journal:  Genome Med       Date:  2013-01-22       Impact factor: 11.117

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.